Related Experiment Video
Updated: May 3, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
20-Deoxyingenol Activates Mitophagy Through TFEB and Promotes Functional Recovery After Spinal Cord Injury
Chenyu Wu1,2,3, Yu Chen1,2,3, Ximiao Chen1,2,3
1Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang Province, Wenzhou, China.
Abstract:
Spinal cord injury (SCI) can lead to permanent paralysis and various motor, sensory and autonomic nervous system dysfunction. The complex pathophysiological processes limit the effectiveness of many clinical treatments. Mitochondria has been reported to play a key role in the pathogenesis of SCI; while mitophagy is a protective mechanism against mitochondrial dysfunction. However, there is recently little drugs that may targeted activate mitophagy to treat SCI. In this study, we evaluated the role of 20-Deoxyingenol (20-DOI) in SCI and explored its potential mechanisms. We used a SCI rat model and evaluated the functional outcomes after the injury. Western blotting and immunofluorescence techniques were used to analyze the levels of mitophagy, apoptosis, and TFEB-related signaling pathways. Our research results show that 20-DOI significantly improves the apoptosis of neural cells after TBHP stimulation and functional recovery after spinal cord injury. In addition, mitophagy, TFEB levels, and apoptosis are related to the mechanism of 20-DOI treatment for spinal cord injury. Specifically, our research results indicate that 20-DOI restored the autophagic flux after injury, thereby inducing mitophagy, eliminating the accumulation of Cyto C, and inhibiting apoptosis. Further mechanism research suggests that 20-DOI may regulate mitophagy by promoting TFEB nuclear translocation. These results indicate that 20-DOI can significantly promote recovery after spinal cord injury, which may be a promising treatment method for spinal cord injury.
Insights
20-Deoxyingenol (20-DOI) treatment improves functional recovery after spinal cord injury (SCI) by promoting mitophagy and inhibiting neural cell apoptosis. This compound shows promise as a novel therapeutic strategy for SCI.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Spinal cord injury (SCI) causes significant neurological deficits due to complex pathophysiological processes.
- Mitochondrial dysfunction is a key factor in SCI pathogenesis, and mitophagy offers a protective mechanism.
- Current treatments for SCI are limited, with a need for novel therapeutic agents targeting mitophagy.
Purpose of the Study:
- To investigate the therapeutic potential of 20-Deoxyingenol (20-DOI) in a rat model of spinal cord injury.
- To elucidate the underlying mechanisms of 20-DOI action, focusing on mitophagy and apoptosis.
- To explore the role of TFEB-related signaling pathways in 20-DOI-mediated neuroprotection.
Main Methods:
- Establishment of a rat model for spinal cord injury (SCI).
- Assessment of functional recovery and neurological outcomes post-injury.
- Analysis of mitophagy, apoptosis, and TFEB signaling using Western blotting and immunofluorescence.
Main Results:
- 20-DOI significantly enhanced functional recovery in SCI rats.
- 20-DOI treatment reduced neural cell apoptosis following TBHP stimulation.
- The study identified restored autophagic flux, induced mitophagy, reduced cytochrome C accumulation, and inhibited apoptosis as key mechanisms.
- 20-DOI was found to promote TFEB nuclear translocation, suggesting a role in regulating mitophagy.
Conclusions:
- 20-Deoxyingenol (20-DOI) demonstrates significant neuroprotective effects and promotes functional recovery after spinal cord injury.
- 20-DOI acts by inducing mitophagy and inhibiting apoptosis, potentially through TFEB pathway activation.
- 20-DOI represents a promising novel therapeutic candidate for treating spinal cord injury.
Related Concept Videos
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Neurogenesis and Regeneration of Nervous Tissue
Secondary Spinal Cord Injury llI: Pathophysiology

